As of June 21, 2025, Toleranzia AB (TOL.ST) reports a Current Ratio of 2.42.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of Toleranzia AB's Current Ratio
Over recent years, Toleranzia AB's Current Ratio has shown significant volatility. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2024-12-31 | 2.42 |
| 2023-12-31 | 3.24 |
| 2022-12-31 | 6.75 |
| 2021-12-31 | 22.74 |
| 2020-12-31 | 11.58 |
This slight downward trend highlights how Toleranzia AB manages its short-term assets and liabilities over time.
Comparing Toleranzia AB's Current Ratio to Peers
To better understand Toleranzia AB's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| Toleranzia AB (TOL.ST) | 2.42 |
| Combigene AB (COMBI.ST) | 17.47 |
| Read Gene SA (RDG.WA) | 10.30 |
| Biogaia AB (BIOG B.ST) | 7.81 |
| Evgen Pharma PLC (EVG.L) | 7.36 |
| Probi AB (PROB.ST) | 6.94 |
Compared to its competitors, Toleranzia AB's Current Ratio is about average compared to peers, reflecting balanced short-term asset management.